title: Synthesis of A/B-ring partial analogs of bruceantin as potential antimalarial agents.
abstract: Bruceantin (1), a classical quassinoid with the highest reported antimalarial activity among the quassinoids examined thus far, was selected as a natural product lead for the design of a series of A/B-ring analogs. A viable strategy for the synthesis of the series was developed. The functionalized A-ring and the C-15 ester moiety in bruceantin are incorporated in all designed compounds. The preliminary bioassay results will be discussed in detail.
authors.affiliation: Department of Medicinal Chemistry, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Guo
authors.forename: S
authors.initials: S
authors.lastname: Vangapandu
authors.forename: A
authors.initials: A
authors.lastname: Nimrod
authors.forename: L A
authors.initials: LA
authors.lastname: Walker
authors.forename: R D
authors.initials: RD
authors.lastname: Sindelar
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D045744:Cell Line, Tumor; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D015394:Molecular Structure; D021261:Parasitic Sensitivity Tests; D010963:Plasmodium falciparum / Q000187:drug effects; D036702:Quassins / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D000962:Antimalarials; D000970:Antineoplastic Agents; D036702:Quassins; C002550:bruceantin